High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.

[1]  W. Trick,et al.  Pathway to Prevention of Nosocomial Clostridium difficile Infection. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Wilt,et al.  Fecal Microbiota Transplantation for Clostridium difficile Infection , 2015, Annals of Internal Medicine.

[3]  P. Tsai,et al.  Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model. , 2015, The Journal of infectious diseases.

[4]  Lisa G Winston,et al.  Burden of Clostridium difficile Infection in the United States , 2015 .

[5]  M. Delmée,et al.  Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). , 2014, The Lancet. Infectious diseases.

[6]  R. Hansen,et al.  Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients , 2014, Infection.

[7]  A. Chott,et al.  Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use , 2014, Antimicrobial Agents and Chemotherapy.

[8]  Zhongqiu Wang,et al.  Identification of Clostridium difficile Ribotype 027 for the First Time in Mainland China , 2014, Infection Control & Hospital Epidemiology.

[9]  Carol Friedman,et al.  Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients , 2013, The American Journal of Gastroenterology.

[10]  D. Hui,et al.  High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Savidge,et al.  Recent insights into Clostridium difficile pathogenesis , 2013, Current opinion in infectious diseases.

[12]  Daniel J. Wilson,et al.  Diverse sources of C. difficile infection identified on whole-genome sequencing. , 2013, The New England journal of medicine.

[13]  David M Aronoff,et al.  Epidemiology of Clostridium difficile Infection , 2013, Journal of pharmacy practice.

[14]  C. Donskey,et al.  Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. , 2013, The Journal of antimicrobial chemotherapy.

[15]  J. Woo,et al.  Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population. , 2013, QJM : monthly journal of the Association of Physicians.

[16]  A. Walker,et al.  Reply to Walk et al. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  T. Ling,et al.  Molecular Epidemiology of Clostridium difficile Infection in a Major Chinese Hospital: an Underrecognized Problem in Asia? , 2013, Journal of Clinical Microbiology.

[18]  D. Gerding,et al.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. , 2013, JAMA internal medicine.

[19]  T. Riley,et al.  Epidemiology of Clostridium difficile infection in Asia , 2013, Antimicrobial Resistance and Infection Control.

[20]  David N. Fisman,et al.  Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection , 2013, Antimicrobial Agents and Chemotherapy.

[21]  T. Peto,et al.  Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. Cairns,et al.  Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  S. Chuang,et al.  Clostridium difficile infection outbreak in a male rehabilitation ward, Hong Kong Special Administrative Region (China), 2011. , 2012, Western Pacific surveillance and response journal : WPSAR.

[24]  Fernanda C. Lessa,et al.  Current Status of Clostridium difficile Infection Epidemiology , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  D. Gerding,et al.  Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  D. Adler,et al.  Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis , 2012, The American Journal of Gastroenterology.

[27]  R. Cavallazzi,et al.  Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis , 2012, The American Journal of Gastroenterology.

[28]  T. Ling,et al.  Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[29]  B. Cooper,et al.  Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. , 2011, The Journal of antimicrobial chemotherapy.

[30]  W. Yam,et al.  Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[31]  Pamela Sears,et al.  Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.

[32]  A. Tatem,et al.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread , 2010, The Lancet Infectious Diseases.

[33]  M. Howell,et al.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. , 2010, Archives of internal medicine.

[34]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[35]  K. To,et al.  Clostridium difficile ribotype 027 arrives in Hong Kong. , 2009, International journal of antimicrobial agents.

[36]  A. Weintraub,et al.  Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. , 2009, International journal of antimicrobial agents.

[37]  D. Paredes-Sabja,et al.  Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). , 2008, Microbiology.

[38]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  C. Donskey,et al.  Vegetative Clostridium difficile Survives in Room Air on Moist Surfaces and in Gastric Contents with Reduced Acidity: a Potential Mechanism To Explain the Association between Proton Pump Inhibitors and C. difficile-Associated Diarrhea? , 2007, Antimicrobial Agents and Chemotherapy.

[40]  E. Kuijper,et al.  First isolation of Clostridium difficile 027 in Japan. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[42]  R. Stafford,et al.  Fluoroquinolone prescribing in the United States: 1995 to 2002. , 2005, The American journal of medicine.

[43]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[44]  T. Koh,et al.  CTX-M and Plasmid-mediated AmpC-Producing Enterobacteriaceae, Singapore , 2004, Emerging infectious diseases.

[45]  Kwok-Hung Chan,et al.  Influenza-related hospitalizations among children in Hong Kong. , 2002, The New England journal of medicine.